These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16700151)

  • 1. Generic and brand-name drugs. Are different criteria sufficiently taken into account before granting market authorisation?
    Laroche ML; Merle L
    Acta Clin Belg; 2006; 61 Suppl 1():48-50. PubMed ID: 16700151
    [No Abstract]   [Full Text] [Related]  

  • 2. Generic and alternative brand-name pharmaceutical equivalents: select with caution.
    Hendeles L; Hochhaus G; Kazerounian S
    Am J Hosp Pharm; 1993 Feb; 50(2):323-9. PubMed ID: 8480793
    [No Abstract]   [Full Text] [Related]  

  • 3. Is bioavailability altered in generic versus brand anticonvulsants?
    Jankovic SM; Ignjatovic Ristic D
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):329-32. PubMed ID: 25440299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription for fairness: a new approach to tort liability of brand-name and generic drug manufacturers.
    Rostron A
    Duke Law J; 2011 Feb; 60(5):1123-91. PubMed ID: 21365961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choice of generic versus brand-name antidepressants in a regulated prescription drug market: evidence from Taiwan.
    Liu YM; Ou HT; Yang YK
    J Ment Health Policy Econ; 2014 Dec; 17(4):163-72. PubMed ID: 25599280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing consumer purchasing patterns of generic versus brand name over-the-counter drugs.
    Kohli E; Buller A
    South Med J; 2013 Feb; 106(2):155-60. PubMed ID: 23380752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generics: keep a balanced view.
    Prescrire Int; 2014 Feb; 23(146):52-5. PubMed ID: 24669392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Generic drugs].
    Delporte JP
    Rev Med Liege; 2002 Jan; 57(1):13-22. PubMed ID: 11899492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Biosimilar' drugs poised to penetrate market.
    Ledford H
    Nature; 2010 Nov; 468(7320):18-9. PubMed ID: 21048737
    [No Abstract]   [Full Text] [Related]  

  • 10. Higher approval standards, consistent practice policies needed for safe use of generic immunosuppressants, say transplant experts.
    Miller JL
    Am J Health Syst Pharm; 1999 Apr; 56(7):604, 607. PubMed ID: 10423202
    [No Abstract]   [Full Text] [Related]  

  • 11. Current regulatory and legal considerations for follow-on biologics.
    Kingham RF; Lietzan E
    Clin Pharmacol Ther; 2008 Nov; 84(5):633-5. PubMed ID: 18716615
    [No Abstract]   [Full Text] [Related]  

  • 12. Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation.
    Ochi N; Yamane H; Hotta K; Fujii H; Isozaki H; Honda Y; Yamagishi T; Kubo T; Tanimoto M; Kiura K; Takigawa N
    Drug Des Devel Ther; 2014; 8():2401-8. PubMed ID: 25584019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system.
    Spence MM; Nguyen LM; Hui RL; Chan J
    Pharmacotherapy; 2012 Nov; 32(11):981-7. PubMed ID: 23074134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of generic competition on the price of brand-name drugs.
    Lexchin J
    Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generic drug approval: a US perspective.
    Nagori BP; Mathur V; Garg S
    Curr Med Res Opin; 2011 Mar; 27(3):541-5. PubMed ID: 21219120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myth: generic drugs are lower quality and less safe than brand-name drugs.
    Canadian Health Services Research Foundation
    J Health Serv Res Policy; 2007 Oct; 12(4):255-6. PubMed ID: 17925080
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of the Safety of a Generic Formulation of Cisplatin in Patients with Thoracic Malignancies].
    Ueda Y; Kondo Y; Suzuki H; Okamoto N; Morishita N; Tamiya M; Shiroyama T; Kumode A; Usui N; Nakano H; Sando M; Tanaka E; Hirashima T
    Gan To Kagaku Ryoho; 2015 Jul; 42(7):827-32. PubMed ID: 26197744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are generic and brand name drugs different in terms of quality?
    Johns Hopkins Med Lett Health After 50; 2000 Feb; 11(12):8. PubMed ID: 10732507
    [No Abstract]   [Full Text] [Related]  

  • 19. Equivocal role of micelles in Eprex adverse events.
    Smiell JM
    Nat Biotechnol; 2003 Nov; 21(11):1265; author reply 1266. PubMed ID: 14595347
    [No Abstract]   [Full Text] [Related]  

  • 20. Equivocal role of micelles in Eprex adverse events.
    Schellekens H; Crommelin DJ
    Nat Biotechnol; 2003 Nov; 21(11):1265; author reply 1266. PubMed ID: 14595346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.